Figure 2
Figure 2. Chimerism studies in skin biopsy. (A) Percentage of epidermal and endothelial chimeric cells in patients with or without GvHD; (▴) epidermal chimeric cells in patients with GVHD, (▵) epidermal chimeric cells in patients without GVHD, (•) endothelial chimeric cells in patients with GVHD, (○) endothelial chimeric cells in patients without GVHD. (B) Relation between apoptotic and chimeric cell numbers in epidermis, endothelium, and inflammatory infiltrate in early and late biopsies of patients with GvHD; (▵) epidermal apoptotic cells, (▴) epidermal chimeric cells,(○) endothelial apoptotic cells, (•) endothelial chimeric cells, (⋄) CD45+ cell, (♦) CD45+ chimeric cells. (C) Distribution patterns of epidermal and endothelial chimeric cells in skin biopsies of patients with GvHD; (▴) epidermal chimeric cells in superficial layers, (▵) epidermal chimeric cells in basal layers, (○) endothelial chimeric cells in upper dermis, (•) endothelial chimeric cells in deep dermis.

Chimerism studies in skin biopsy. (A) Percentage of epidermal and endothelial chimeric cells in patients with or without GvHD; (▴) epidermal chimeric cells in patients with GVHD, (▵) epidermal chimeric cells in patients without GVHD, (•) endothelial chimeric cells in patients with GVHD, (○) endothelial chimeric cells in patients without GVHD. (B) Relation between apoptotic and chimeric cell numbers in epidermis, endothelium, and inflammatory infiltrate in early and late biopsies of patients with GvHD; (▵) epidermal apoptotic cells, (▴) epidermal chimeric cells,(○) endothelial apoptotic cells, (•) endothelial chimeric cells, (⋄) CD45+ cell, (♦) CD45+ chimeric cells. (C) Distribution patterns of epidermal and endothelial chimeric cells in skin biopsies of patients with GvHD; (▴) epidermal chimeric cells in superficial layers, (▵) epidermal chimeric cells in basal layers, (○) endothelial chimeric cells in upper dermis, (•) endothelial chimeric cells in deep dermis.

Close Modal

or Create an Account

Close Modal
Close Modal